Jenny Smith

NPI: 1912115460
Total Payments
$3,528
2024 Payments
$596.81
Companies
26
Transactions
226
Medicare Patients
2,851
Medicare Billing
$239,969

Payment Breakdown by Category

Food & Beverage$3,528 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,528 226 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,384 88 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $924.93 59 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $197.95 14 $0 (2024)
Celgene Corporation $186.28 13 $0 (2024)
Janssen Biotech, Inc. $143.24 8 $0 (2024)
PFIZER INC. $93.67 6 $0 (2024)
Ardelyx, Inc. $66.18 3 $0 (2024)
Valeant Pharmaceuticals North America LLC $61.33 4 $0 (2017)
Braintree Laboratories, Inc. $58.83 4 $0 (2022)
RedHill Biopharma Inc. $54.92 3 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $596.81 36 ABBVIE INC. ($235.00)
2023 $458.98 27 AbbVie Inc. ($245.05)
2022 $772.31 49 ABBVIE INC. ($297.57)
2021 $632.46 42 AbbVie Inc. ($261.94)
2020 $267.80 19 AbbVie Inc. ($117.63)
2019 $437.58 28 AbbVie, Inc. ($205.12)
2018 $171.40 11 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($114.76)
2017 $190.97 14 Valeant Pharmaceuticals North America LLC ($61.33)

All Payment Transactions

226 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/02/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $16.25 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/12/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $25.59 General
Category: Immunology
11/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.62 General
Category: IMMUNOLOGY
11/01/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $15.26 General
Category: VIROLOGY
10/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $23.22 General
Category: IMMUNOLOGY
10/10/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $15.59 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/23/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $19.33 General
Category: VIROLOGY
09/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $13.69 General
Category: INTERNAL MEDICINE
08/23/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $17.43 General
Category: VIROLOGY
08/15/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $16.03 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/09/2024 Echosens North America, Inc. FibroScan (Device) Food and Beverage Cash or cash equivalent $15.84 General
Category: Elastography
07/30/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $14.94 General
Category: VIROLOGY
07/22/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $23.27 General
Category: GASTROENTEROLOGY
07/17/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $9.31 General
Category: IMMUNOLOGY
07/15/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $12.92 General
Category: IMMUNOLOGY
07/11/2024 ABBVIE INC. CREON (Drug), VIBERZI, LINZESS Food and Beverage In-kind items and services $28.87 General
Category: ENDOCRINOLOGY
06/21/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $13.75 General
Category: VIROLOGY
06/14/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $17.45 General
Category: Neuroscience
06/12/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.88 General
Category: Gastroenterology
06/11/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $22.70 General
Category: GASTROENTEROLOGY
06/10/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $13.42 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
05/14/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $12.95 General
Category: VIROLOGY
05/08/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $4.82 General
Category: IMMUNOLOGY
05/07/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.00 General
Category: Gastroenterology
04/25/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.57 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 730 826 $381,914 $64,652
2022 13 852 1,067 $431,058 $71,864
2021 15 734 894 $365,647 $62,899
2020 15 535 641 $257,890 $40,555
Total Patients
2,851
Total Services
3,428
Medicare Billing
$239,969
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 63 63 $87,696 $11,943 13.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 106 127 $17,526 $7,330 41.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 100 100 $19,400 $5,927 30.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 72 72 $56,520 $5,820 10.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 44 44 $50,952 $5,322 10.4%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 31 32 $34,560 $5,182 15.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 43 43 $12,642 $4,771 37.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 52 55 $11,220 $4,626 41.2%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 99 166 $19,920 $3,160 15.9%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 15 16 $17,280 $2,594 15.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 21 21 $5,838 $2,536 43.4%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 20 21 $22,680 $2,531 11.2%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 23 24 $17,280 $1,690 9.8%
43450 Dilation of esophagus Facility 2023 41 42 $8,400 $1,221 14.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 89 89 $123,888 $16,561 13.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 141 181 $24,978 $10,079 40.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 133 133 $25,802 $8,429 32.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 84 84 $65,940 $7,073 10.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2022 153 314 $37,680 $6,507 17.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 58 58 $67,164 $4,852 7.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 45 45 $13,230 $4,764 36.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 25 25 $27,000 $4,276 15.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 37 41 $8,364 $3,812 45.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 12 12 $12,960 $1,978 15.3%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 19 20 $14,400 $1,687 11.7%

About Jenny Smith

Jenny Smith is a Gastroenterology healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912115460.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenny Smith has received a total of $3,528 in payments from pharmaceutical and medical device companies, with $596.81 received in 2024. These payments were reported across 226 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,528).

As a Medicare-enrolled provider, Smith has provided services to 2,851 Medicare beneficiaries, totaling 3,428 services with total Medicare billing of $239,969. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Maryville, TN
  • Active Since 05/18/2007
  • Last Updated 07/06/2016
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1912115460

Products in Payments

  • XIFAXAN (Drug) $785.05
  • MAVYRET (Drug) $501.81
  • ENTYVIO (Biological) $186.98
  • ZEPOSIA (Drug) $186.28
  • RINVOQ (Biological) $161.11
  • Humira (Biological) $149.02
  • HUMIRA (Biological) $148.99
  • LINZESS (Drug) $146.65
  • REMICADE (Biological) $102.72
  • TRULANCE (Drug) $90.01
  • XELJANZ (Drug) $81.99
  • CREON (Drug) $81.21
  • UCERIS (Drug) $78.41
  • SKYRIZI (Biological) $75.30
  • IBSRELA (Drug) $66.18
  • ZENPEP (Drug) $63.39
  • VIBERZI (Drug) $56.10
  • Talicia (Drug) $54.92
  • OCALIVA (Drug) $52.61
  • INJECTAFER (Drug) $41.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Maryville